Abstract
SummaryBetween 1975 to 1986, 43 patients with mixed malignant mullerian tumours were studied at the Alexandra University Hospital. Among these, 33 were homologous and 10 heterologous.Treatment included appropriate combinations of surgery, radiotherapy and combination chemotherapy. Twenty per cent were recurrence free for 2 years and only 11 per cent survived more than 5 years.Homologous tumours occurred more frequently than heterologous and were of better prognosis.The incidence of mixed malignant mullerian tumours among malignant tumours of the uterine corpus was high in our study (5 per cent). Primary factors related to prognosis were the size of the uterus and the surgical stage when the patient presented; and the differentiation of the tumour.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
